Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study

This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation ra...

Full description

Saved in:
Bibliographic Details
Published inOpen life sciences Vol. 20; no. 1; pp. 20251088 - 6
Main Authors He, Tao, Song, Lian-Qiang, Weng, Xiao-Yu, Pan, Peng, Ding, Hui, Liu, Mei-Qin, Qiu, Shi-Lin, Sun, Shan-Ming
Format Journal Article
LanguageEnglish
Published Poland De Gruyter 05.05.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
AbstractList This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca 2+ ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca 2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca 2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca 2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca 2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca 2+ ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca 2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca 2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca 2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca 2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People's Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People's Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.
Author Qiu, Shi-Lin
He, Tao
Liu, Mei-Qin
Sun, Shan-Ming
Song, Lian-Qiang
Weng, Xiao-Yu
Pan, Peng
Ding, Hui
Author_xml – sequence: 1
  givenname: Tao
  surname: He
  fullname: He, Tao
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 2
  givenname: Lian-Qiang
  surname: Song
  fullname: Song, Lian-Qiang
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 3
  givenname: Xiao-Yu
  surname: Weng
  fullname: Weng, Xiao-Yu
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 4
  givenname: Peng
  surname: Pan
  fullname: Pan, Peng
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 5
  givenname: Hui
  surname: Ding
  fullname: Ding, Hui
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 6
  givenname: Mei-Qin
  surname: Liu
  fullname: Liu, Mei-Qin
  organization: Department of Endocrinology, Weifang Respiratory Disease Hospital, Shandong Second Medical University, Weifang, 261000, China
– sequence: 7
  givenname: Shi-Lin
  surname: Qiu
  fullname: Qiu, Shi-Lin
  email: shilinshineslq@126.com
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
– sequence: 8
  givenname: Shan-Ming
  surname: Sun
  fullname: Sun, Shan-Ming
  email: sunshanming2023@163.com
  organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40356724$$D View this record in MEDLINE/PubMed
BookMark eNp1kkFv1DAQhSNUREvplSPKkUta27GdmAuqVkArVeICZ8uxx1svTrzYzqL8e5xuqdoDJ49m3nwjz7y31ckUJqiq9xhdYobZ1eCCbwgirMGo719VZ6QVuGEUk5Nn8Wl1kdIOIYQZJQzxN9UpRS3jHaFn1bzxbnJa-TqCh4OaNNTB1m6yXo2jyiEu9ajiL4ipJOt8D3VR-VllF6ZVmeAA0eVljWevIZbKAWodvMsufaqvCzjHkPagHwopz2Z5V722yie4eHzPq59fv_zY3DR337_dbq7vGk05zY3pe6rE0BNG-CA6YyjTHeuo5YIJqgbbM6E1NaI33HbdMHDNOmLADrwXhLfteXV75JqgdnIfXfnKIoNy8iER4laqmJ32ILHttEZgbKvLmrhVZkDQaTEwLFiru8L6fGTt52EEo2HKUfkX0JeVyd3LbThITBDvcc8K4eMjIYbfM6QsR5c0eK8mCHOSLUFti6gQokg_PB_2NOXf4Yrg8ijQZbcpgn2SYCRXc8jVHHI1h1zNURrEseGP8hmigW2clxLIXZjjVI7wn0aCcPsXa33C9Q
Cites_doi 10.1136/gut.2005.082909
10.1080/07853890.2024.2398725
10.3390/nu13082583
10.1016/j.intimp.2021.108235
10.1016/S0140-6736(17)32448-0
10.1053/j.gastro.2006.12.038
10.1089/ars.2012.4530
10.1053/j.gastro.2016.02.032
10.1152/ajpgi.00455.2015
10.1097/CM9.0000000000003221
10.5217/ir.2019.09156
10.1016/B978-0-12-824472-2.00011-7
10.1097/MS9.0000000000001297
10.5009/gnl17216
10.3390/cancers16162911
10.3390/jcm5120118
10.2478/fzm-2024-0003
10.1515/jomb-2017-0050
10.1016/j.molmed.2008.09.006
10.1093/ecco-jcc/jjy215
10.3390/ijms25137062
10.1186/s43046-024-00208-4
10.1038/ajg.2015.6
ContentType Journal Article
Copyright 2025 the author(s), published by De Gruyter.
2025 the author(s), published by De Gruyter 2025 the author(s), published by De Gruyter
Copyright_xml – notice: 2025 the author(s), published by De Gruyter.
– notice: 2025 the author(s), published by De Gruyter 2025 the author(s), published by De Gruyter
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1515/biol-2025-1088
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

CrossRef

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2391-5412
EndPage 6
ExternalDocumentID oai_doaj_org_article_1f7cc0edf3c5426fadb0e7c9b51953c7
PMC12068185
40356724
10_1515_biol_2025_1088
10_1515_biol_2025_1088201
Genre Journal Article
GroupedDBID 5VS
AAFWJ
ABFKT
ACGFS
ADBBV
AENEX
AFBDD
AFPKN
AHGSO
ALMA_UNASSIGNED_HOLDINGS
BCNDV
EBS
ECGQY
GROUPED_DOAJ
KQ8
M~E
PGMZT
QD8
RPM
Y2W
AAYXX
CITATION
AIKXB
EJD
IPNFZ
M48
NPM
RIG
SLJYH
7X8
5PM
ID FETCH-LOGICAL-c464t-d884a9b82526b97dd45c7574f69594abf859cc4d98d6f77bb6c572defb6892633
IEDL.DBID DOA
ISSN 2391-5412
IngestDate Wed Aug 27 01:31:43 EDT 2025
Thu Aug 21 18:26:42 EDT 2025
Thu May 15 20:01:06 EDT 2025
Fri May 16 02:48:47 EDT 2025
Sun Jul 06 05:08:16 EDT 2025
Thu Jul 10 10:34:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords platelet/lymphocyte ratio
ulcerative colitis
disease assessment
neutrophil/lymphocyte ratio
Language English
License This work is licensed under the Creative Commons Attribution 4.0 International License.
http://creativecommons.org/licenses/by/4.0
2025 the author(s), published by De Gruyter.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c464t-d884a9b82526b97dd45c7574f69594abf859cc4d98d6f77bb6c572defb6892633
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this study.
OpenAccessLink https://doaj.org/article/1f7cc0edf3c5426fadb0e7c9b51953c7
PMID 40356724
PQID 3203304999
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_1f7cc0edf3c5426fadb0e7c9b51953c7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12068185
proquest_miscellaneous_3203304999
pubmed_primary_40356724
crossref_primary_10_1515_biol_2025_1088
walterdegruyter_journals_10_1515_biol_2025_1088201
PublicationCentury 2000
PublicationDate 2025-05-05
PublicationDateYYYYMMDD 2025-05-05
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-05
  day: 05
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
PublicationTitle Open life sciences
PublicationTitleAlternate Open Life Sci
PublicationYear 2025
Publisher De Gruyter
Publisher_xml – name: De Gruyter
References 2025052707380701415_j_biol-2025-1088_ref_003
2025052707380701415_j_biol-2025-1088_ref_025
2025052707380701415_j_biol-2025-1088_ref_002
2025052707380701415_j_biol-2025-1088_ref_024
2025052707380701415_j_biol-2025-1088_ref_005
2025052707380701415_j_biol-2025-1088_ref_004
2025052707380701415_j_biol-2025-1088_ref_021
2025052707380701415_j_biol-2025-1088_ref_020
2025052707380701415_j_biol-2025-1088_ref_001
2025052707380701415_j_biol-2025-1088_ref_023
2025052707380701415_j_biol-2025-1088_ref_022
2025052707380701415_j_biol-2025-1088_ref_007
2025052707380701415_j_biol-2025-1088_ref_006
2025052707380701415_j_biol-2025-1088_ref_009
2025052707380701415_j_biol-2025-1088_ref_008
2025052707380701415_j_biol-2025-1088_ref_014
2025052707380701415_j_biol-2025-1088_ref_013
2025052707380701415_j_biol-2025-1088_ref_016
2025052707380701415_j_biol-2025-1088_ref_015
2025052707380701415_j_biol-2025-1088_ref_010
2025052707380701415_j_biol-2025-1088_ref_012
2025052707380701415_j_biol-2025-1088_ref_011
2025052707380701415_j_biol-2025-1088_ref_018
2025052707380701415_j_biol-2025-1088_ref_017
2025052707380701415_j_biol-2025-1088_ref_019
References_xml – ident: 2025052707380701415_j_biol-2025-1088_ref_013
  doi: 10.1136/gut.2005.082909
– ident: 2025052707380701415_j_biol-2025-1088_ref_006
  doi: 10.1080/07853890.2024.2398725
– ident: 2025052707380701415_j_biol-2025-1088_ref_009
  doi: 10.3390/nu13082583
– ident: 2025052707380701415_j_biol-2025-1088_ref_014
– ident: 2025052707380701415_j_biol-2025-1088_ref_018
  doi: 10.1016/j.intimp.2021.108235
– ident: 2025052707380701415_j_biol-2025-1088_ref_002
  doi: 10.1016/S0140-6736(17)32448-0
– ident: 2025052707380701415_j_biol-2025-1088_ref_012
  doi: 10.1053/j.gastro.2006.12.038
– ident: 2025052707380701415_j_biol-2025-1088_ref_021
  doi: 10.1089/ars.2012.4530
– ident: 2025052707380701415_j_biol-2025-1088_ref_011
  doi: 10.1053/j.gastro.2016.02.032
– ident: 2025052707380701415_j_biol-2025-1088_ref_024
  doi: 10.1152/ajpgi.00455.2015
– ident: 2025052707380701415_j_biol-2025-1088_ref_001
  doi: 10.1097/CM9.0000000000003221
– ident: 2025052707380701415_j_biol-2025-1088_ref_017
  doi: 10.5217/ir.2019.09156
– ident: 2025052707380701415_j_biol-2025-1088_ref_015
  doi: 10.1016/B978-0-12-824472-2.00011-7
– ident: 2025052707380701415_j_biol-2025-1088_ref_005
  doi: 10.1097/MS9.0000000000001297
– ident: 2025052707380701415_j_biol-2025-1088_ref_022
  doi: 10.5009/gnl17216
– ident: 2025052707380701415_j_biol-2025-1088_ref_007
  doi: 10.3390/cancers16162911
– ident: 2025052707380701415_j_biol-2025-1088_ref_020
  doi: 10.3390/jcm5120118
– ident: 2025052707380701415_j_biol-2025-1088_ref_003
  doi: 10.2478/fzm-2024-0003
– ident: 2025052707380701415_j_biol-2025-1088_ref_016
  doi: 10.1515/jomb-2017-0050
– ident: 2025052707380701415_j_biol-2025-1088_ref_023
  doi: 10.1016/j.molmed.2008.09.006
– ident: 2025052707380701415_j_biol-2025-1088_ref_019
  doi: 10.1093/ecco-jcc/jjy215
– ident: 2025052707380701415_j_biol-2025-1088_ref_004
  doi: 10.3390/ijms25137062
– ident: 2025052707380701415_j_biol-2025-1088_ref_008
  doi: 10.1186/s43046-024-00208-4
– ident: 2025052707380701415_j_biol-2025-1088_ref_025
– ident: 2025052707380701415_j_biol-2025-1088_ref_010
  doi: 10.1038/ajg.2015.6
SSID ssj0001542506
Score 2.343359
Snippet This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
walterdegruyter
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 20251088
SubjectTerms disease assessment
neutrophil/lymphocyte ratio
platelet/lymphocyte ratio
ulcerative colitis
Title Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
URI https://www.degruyter.com/doi/10.1515/biol-2025-1088
https://www.ncbi.nlm.nih.gov/pubmed/40356724
https://www.proquest.com/docview/3203304999
https://pubmed.ncbi.nlm.nih.gov/PMC12068185
https://doaj.org/article/1f7cc0edf3c5426fadb0e7c9b51953c7
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOgltOnLbRNUKPRk4tVbvaUlIRTaUwO5CT3bQuINuzYl_74zsjfJ9kEvvRlZ2JJm5PnkmfmGkDdgk2PMnrU2i9yKwGzrdbDtwosA8CMXzjAb-dNndXomPp7L8zulvjAmbKIHnhbucFF0jF1OhUcJ1qT4FLqsow1Ii8JjzSMHm3fnMDXlB4MudmpmaQSbfYicRqASDHk3a5mVWytUyfr_hDB_D5Tc_VGd2Cl_XY3Xw8ZpWm3RyUOyO4NIejQN_hG5l_s9cn8qK3n9mIwz2ecFxYoo1cdPl4WCLoH4L6tbnV5iWM5qDY0UICC9Jf3GnmAtMxa1w-vxIuaJHZzGGiu3fkeP4MHDarnJ0qSVo_YJOTs5_vLhtJ3LK7RRKDG0yRjhbYAjIlPB6pSEjFpqUZSVVvhQjLQximRNUkXrEFSUmqVcgjKWKc6fkp1-2efnhAZjysKokLOXgnvtuUhayRx0BHgRbEPebpbbXU0sGg5PHyAYh4JxKBjkKjUNeY_SuOmF7Ne1AXTCzTrh_qUTDXm9kaWD3YIuEN_n5bh2nHX4AwdQcUOeTbK9eZXouFSaiYaYLalvjWX7Tv_9W2XkXrBOIfJpCPtFQdz8SVj_Zb6Av178jym_JA-qcmMopnxFdobVmPcBLg3hoO6Mn2W0GRc
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKwSXijfhaSQkTlGzjp_cFkRZoC0HWqm3KH61SLsJyiZC_ffMJNltl8KFW5TYiZNvnPlsj78h5A34ZOdCyVITeEi5ZSYtlTXptOQW6EeIOcPdyIdHcn7Cv5yK0yt7YTCs0oezprtoB4XUPV-7DifKNloD4IH3UKEIAGaooglDuPN2ubhJdiSwfz0hO7P5p-_fLmdaBNhlJkfFxuu1tzxSL9z_N7Z5PWhy91e_oL1p7RW_tH-X7I6Eks4GC7hHboTqPrk1pJi8eEC6UfhzQTE7Sr_eT-tIwa7AFJb9EjtdYohOs4KTFOggvRQAx5LgOQMmuMPjbuHCoBROXR83t3pHZ3DjtqnXOzZpr1f7kJzsfzz-ME_HVAup45K3qdeal8bCcJFJa5T3XDglFI_SCMNLG7UwznFvtJdRKWulE4r5EK3Uhsk8f0QmVV2FJ4RareNUSxtCKXheqjLnXkkRrHJANaxJyNv15y5-DooaBY5EAJgCgSkQGNQt1Ql5j2hsSqESdn-ibs6KsWMV06icy4KPuQOcZSy9zYJyxqJsTu5UQl6vsSyg5-BySFmFulsVOctwMgcYckIeD9huHsWzXEjFeEL0Fupbbdm-Uv0479W5pyyTyIISwv4wkGL8Paz-8b7AxZ7-T6VX5Pb8-PCgOPh89PUZudMbNoZkiudk0jZdeAG0qbUvx37xG_MSGsE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFH6CqUBcKtYSViMhcYqa8W5uwzIMW0GCStwirwWpTaosQv332ElmylC4cIsSO3HyPed9tp-_B_A0-mRrvca58tTn1GCVa2FUPtfURPrhA8FpN_LHA746pO--sXU0YTuFVTp_1PRn3aiQuu9q26eJso3WQPTA-0mhKAKMk4pmHMKdunAZdjhXhM5gZ7F68-XT-UQLi2ZZ8Emw8WLlLYc06Pb_jWxejJnc_TmsZ28a-5tbWl6H3YlPosVoADfgkq9uwpUxw-TZLegn3c9jlJKjDMv9qA4omlW0hJNhhR2dpAidpo0nUWSD6Fz_O5WMjtOn_HbpuD-2fhQKR3YIm2ufo0W8cdfU6w2baJCrvQ2Hy9dfX67yKdNCbimnXe6kpFqZOFrE3CjhHGVWMEEDV0xRbYJkylrqlHQ8CGEMt0xg54PhUmFOyB2YVXXl7wIyUoa55MZ7zSjRQhPqBGfeCBuZhlEZPFt_7vJ0FNQo00AkAlMmYMoETJItlRm8SGhsSiUh7OFE3RyVU78q50FYW3gXiI0486CdKbywyiTVHGJFBk_WWJax46TVEF35um9Lgos0lxMJcgZ7I7abR9GCMC4wzUBuob7Vlu0r1Y_vgzj3HBc8kaAM8B8GUk5_h_Yf7xup2L3_qfQYrn5-tSw_vD14fx-uDXadAjLZA5h1Te8fRtLUmUdTt_gFIkgZ5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+relevance+of+inflammatory+markers+in+the+evaluation+of+severity+of+ulcerative+colitis%3A+A+retrospective+study&rft.jtitle=Open+life+sciences&rft.au=He%2C+Tao&rft.au=Song%2C+Lian-Qiang&rft.au=Weng%2C+Xiao-Yu&rft.au=Pan%2C+Peng&rft.date=2025-05-05&rft.issn=2391-5412&rft.eissn=2391-5412&rft.volume=20&rft.issue=1&rft.spage=20251088&rft_id=info:doi/10.1515%2Fbiol-2025-1088&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2391-5412&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2391-5412&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2391-5412&client=summon